The United States is experiencing a marked increase in rates of diabetes mellitus and metabolic syndrome, almost certainly in part due to the increase in obesity rates. This phenomenon is likely to also result in an increased risk of coronary artery disease as risk factors increase exponentially. This article defines diabetic dyslipidemia, the rationale for aggressive treatment, and options for ongoing management, including nonpharmacologic therapy and medications, alone or in combination, for management of all aspects of the lipid profile.
机构:
Univ Hosp Ctr Zagreb, Dept Internal Med, Div Metab Dis, Kispaticeva 21, Zagreb 10000, Croatia
Univ Zagreb, Sch Med, Zagreb 10000, CroatiaUniv Hosp Ctr Zagreb, Dept Internal Med, Div Metab Dis, Kispaticeva 21, Zagreb 10000, Croatia
Muacevic-Katanec, Diana
Reiner, Zeljko
论文数: 0引用数: 0
h-index: 0
机构:
Univ Hosp Ctr Zagreb, Dept Internal Med, Div Metab Dis, Kispaticeva 21, Zagreb 10000, Croatia
Univ Zagreb, Sch Med, Zagreb 10000, CroatiaUniv Hosp Ctr Zagreb, Dept Internal Med, Div Metab Dis, Kispaticeva 21, Zagreb 10000, Croatia
机构:
Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, TaiwanTaipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan
Hsueh, Yu-Chun
Chou, Chuan-Liang
论文数: 0引用数: 0
h-index: 0
机构:
Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, TaiwanTaipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan
Chou, Chuan-Liang
Lee, Ting-I.
论文数: 0引用数: 0
h-index: 0
机构:
Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, TaiwanTaipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan